Alteogen Inc
KOSDAQ:196170

Watchlist Manager
Alteogen Inc Logo
Alteogen Inc
KOSDAQ:196170
Watchlist
Price: 448 000 KRW 6.29%
Market Cap: 23.9T KRW
Have any thoughts about
Alteogen Inc?
Write Note

Relative Value

The Relative Value of one Alteogen Inc stock under the Base Case scenario is 58 238.74 KRW. Compared to the current market price of 448 000 KRW, Alteogen Inc is Overvalued by 87%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
58 238.74 KRW
Overvaluation 87%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
0
vs Industry
13
Median 3Y
68.4
Median 5Y
69.3
Industry
8.1
Forward
296.8
vs History
vs Industry
0
Median 3Y
-102.1
Median 5Y
-102.1
Industry
23
Forward
3 081.4
vs History
14
vs Industry
0
Median 3Y
-219
Median 5Y
-69.4
Industry
23.4
vs History
vs Industry
Median 3Y
-43.2
Median 5Y
-47.7
Industry
27.3
vs History
0
vs Industry
0
Median 3Y
17.1
Median 5Y
17.7
Industry
2.6
vs History
0
vs Industry
12
Median 3Y
64.1
Median 5Y
66.2
Industry
8.1
Forward
294.8
vs History
1
vs Industry
5
Median 3Y
327
Median 5Y
186.8
Industry
9.6
vs History
vs Industry
0
Median 3Y
-158
Median 5Y
-140.5
Industry
4.3
Forward
-4 786.8
vs History
vs Industry
100
Median 3Y
-135.6
Median 5Y
-122.9
Industry
3.8
Forward
-3 286.5
vs History
14
vs Industry
0
Median 3Y
-207.5
Median 5Y
-63
Industry
6
vs History
vs Industry
Median 3Y
-65.4
Median 5Y
-71.8
Industry
3.8
vs History
3
vs Industry
3
Median 3Y
32.8
Median 5Y
41.4
Industry
4.8

Multiples Across Competitors

Competitors Multiples
Alteogen Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Alteogen Inc
KOSDAQ:196170
22.4T KRW 246.6 -17 460 -4 383.6 -2 735.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 563 478.2 -178 533.6 -216 796.7 -214 322.8
US
Abbvie Inc
NYSE:ABBV
301B USD 5.4 59.2 14.8 22.8
US
Amgen Inc
NASDAQ:AMGN
162B USD 5 38.3 17.8 33.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
127.5B USD 12 -265.7 26.9 28.2
US
Gilead Sciences Inc
NASDAQ:GILD
115.4B USD 4.1 916 10.2 10.2
US
Epizyme Inc
F:EPE
94.1B EUR 1 875.5 -478.6 -521.2 -507.3
AU
CSL Ltd
ASX:CSL
138B AUD 6 33.9 20.9 26
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
88.6B USD 6.4 19 17.5 19.4
US
Seagen Inc
F:SGT
39.3B EUR 18.1 -55.4 -59.5 -53.7
NL
argenx SE
XBRU:ARGX
34.1B EUR 18.5 -129.9 -104.5 -76.1
P/E Multiple
Earnings Growth
KR
Alteogen Inc
KOSDAQ:196170
Average P/E: 213.3
Negative Multiple: -17 460
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -178 533.6 N/A
US
Abbvie Inc
NYSE:ABBV
59.2
412%
US
Amgen Inc
NASDAQ:AMGN
38.3
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -265.7
42%
US
Gilead Sciences Inc
NASDAQ:GILD
916
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -478.6 N/A
AU
CSL Ltd
ASX:CSL
33.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
KR
Alteogen Inc
KOSDAQ:196170
Average EV/EBITDA: 18
Negative Multiple: -4 383.6
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 796.7 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.8
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.9
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -521.2 N/A
AU
CSL Ltd
ASX:CSL
20.9
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.5
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
KR
Alteogen Inc
KOSDAQ:196170
Average EV/EBIT: 23.4
Negative Multiple: -2 735.2
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 322.8 N/A
US
Abbvie Inc
NYSE:ABBV
22.8
88%
US
Amgen Inc
NASDAQ:AMGN
33.7
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -507.3 N/A
AU
CSL Ltd
ASX:CSL
26
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.4
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.1 N/A

See Also

Discover More
Back to Top